Allergy Immunotherapy Market Foreseen to Draw USD 4324.7 Million by 2023 at 10.85% of CAGR: Declares MRFR – Markets Insider
|
Allergy Immunotherapy Market Foreseen to Draw USD 4324.7 Million by 2023 at 10.85% of CAGR: Declares MRFR
Markets Insider PUNE, India, Aug. 3, 2017 /PRNewswire/ — Market Research Future published a Cooked research report on “Global Allergy Immunotherapy Market Research Report – Forecast to 2023″ – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2023. Sublingual Allergy Immunotherapy Market Foreseen to Grow Exponentially Over 2017 – 2025satPRnews (press release) |
|
European Patent Office to Grant MilliporeSigma’s Patent Application for CRISPR Technology
Canada NewsWire (press release) BILLERICA, Mass., Aug. 3, 2017 /CNW/ — MilliporeSigma today announced that the European Patent Office (EPO) has issued a “Notice of Intention to Grant” for MilliporeSigma’s patent application covering the company’s CRISPR technology used in a … |
PR Newswire (press release) |
European Patent Office to Grant MilliporeSigma’s Patent Application for CRISPR Technology
PR Newswire (press release) Merck’s patent application covers integration of an external DNA sequence into the chromosome of eukaryotic cells using CRISPR. The patent will give Merck’s CRISPR genomic integration technology broad protection, further strengthening the company’s … |
HuffPost |
CRISPR Helped ‘Edit’ A Human Embryo — But That’s Not All It Can Do
HuffPost Researchers at Oregon Health & Science University, lead by Shoukhrat Mitalipov, used a tool called the Clustered Regularly Interspaced Short Palindromic Repeats, or CRISPR ― a DNA cutting and splicing machine that scientists can “program” to target a … US scientists have corrected a genetic heart mutation in embryos using CRISPRTechCrunch Better babies through CrisprBulletin of the Atomic Scientists Scientists successfully used CRISPR to fix a mutation that causes disease. This is huge.Vox WIRED –Chemical & Engineering News –The Scientist –MIT Technology Review all 446 news articles » |
Markets Insider |
BioTaiwan 2017 concludes, another successful gathering of the region’s life science community
Markets Insider BioBusiness Asia this year featured a wide range of session themes with a particular emphasis on emerging technologies including precision medicine, next generation sequencing, artificial intelligence (AI), synthetic biology, cancer immunotherapy, and … |
Observer |
Editing Human Embryos With CRISPR Is Moving Ahead—Now’s the Time to Consider Ethics
Observer Editing Human Embryos With CRISPR Is Moving Ahead—Now’s the Time to Consider Ethics. By Jessica Berg • 08/02/17 5:05pm. There’s still a way to go from editing single-cell embryos to a full-term ‘designer baby.’ ZEISS Microscopy. The announcement by … |